Search
Search Results
##search.searchResults.foundPlural##
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2335PDF: 1347HTML: 17105Bassan Fig.1: 154Bassan Fig.2: 168Bassan Fig.4: 145Fig.3: 214 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3628PDF: 2552HTML: 1525 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2409PDF: 1876HTML: 154 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1689PDF: 660HTML: 2438 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2660PDF: 1643HTML: 2376Table1: 200 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1927PDF: 793HTML: 547 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3777PDF: 1496HTML: 190 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3387PDF: 1382HTML: 2683 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1235PDF: 611HTML: 6806 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3759PDF: 1643HTML: 83 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3301PDF: 1480HTML: 5959Fig1-Ag-Pil: 243Ag-Pil Fig.2: 243 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4493PDF: 1744HTML: 1095 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4499PDF: 1538HTML: 1565Untitled: 243 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1722PDF: 416HTML: 223 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7742PDF: 2455HTML: 1745Table 1.: 227Table 2.: 239Table 3.: 222Table 4.: 216 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1155PDF: 514HTML: 251 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1822PDF: 699HTML: 2423Untitled: 164Figure 1 a: 171Figure 1 b: 181Fig 1 c: 161Figure 1 d: 209 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3255PDF: 795HTML: 2977Figure 1a and 1b: 159Figure 2: 166Figure 3: 185Figure 4: 169Figure 5: 170Tables 1-5: 158 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4033PDF: 1071HTML: 3608Untitled: 180Cneo. Fig.1: 117Untitled: 109Untitled: 137Untitled: 137 -
-
Acquired Hemophilia A successfully treated with rituximab
2108PDF: 1164HTML: 1460Figure 1: 200 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4436PDF: 3649HTML: 226 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1469PDF: 854HTML: 1079Untitled: 192 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1385HTML: 334PDF: 970Suppl. Files: 477







